SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-10-041164
Filing Date
2010-08-04
Accepted
2010-08-04 15:59:08
Documents
2
Period of Report
2010-08-04

Document Format Files

Seq Description Document Type Size
1 v192466_6k.htm 6-K 36046
2 GRAPHIC logo.jpg GRAPHIC 4529
  Complete submission text file 0001144204-10-041164.txt   43819
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 10991002
SIC: 2834 Pharmaceutical Preparations